Vyfhuis, M. A., Bhooshan, N., Burrows, W. M., Turner, M., Suntharalingam, M., Donahue, J., . . . Mohindra, P. (2017). Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer. Adv Radiat Oncol.
Chicago-tyylinen lähdeviittausVyfhuis, Melissa A.L., et al. "Oncological Outcomes From Trimodality Therapy Receiving Definitive Doses of Neoadjuvant Chemoradiation (≥60 Gy) and Factors Influencing Consideration for Surgery in Stage III Non-small Cell Lung Cancer." Adv Radiat Oncol 2017.
MLA-viiteVyfhuis, Melissa A.L., et al. "Oncological Outcomes From Trimodality Therapy Receiving Definitive Doses of Neoadjuvant Chemoradiation (≥60 Gy) and Factors Influencing Consideration for Surgery in Stage III Non-small Cell Lung Cancer." Adv Radiat Oncol 2017.